Zomedica Corp Stock Price, News & Analysis

Welcome to our dedicated page for Zomedica news (Ticker: ZOM), a resource for investors and traders seeking the latest updates and insights on Zomedica stock.

The Zomedica Corp. (ZOM) news page on Stock Titan highlights company announcements, product updates, financial results, and strategic initiatives in equine and companion animal health. Zomedica describes itself as an animal health company offering point-of-care diagnostic and therapeutic device products, and its news flow reflects developments across platforms such as PulseVet, Assisi, TRUFORMA, TRUVIEW, VETGuardian, and VETIGEL.

Readers can find coverage of new product launches and enhancements, including the Assisi Loop Lounge tPEMF therapy bed, expansions of the TRUFORMA diagnostic menu such as the equine progesterone assay and feline cobalamin and folate testing, and updates on the TRUVIEW digital cytology microscope. News items also discuss the VETGuardian Zero Touch monitoring system and how it is being presented to veterinarians through educational webinars.

Zomedica’s releases frequently address distribution and market expansion, such as the expanded agreement with Grovet b.v. in the Netherlands, which broadens access to equine therapeutic devices, VETIGEL hemostatic gel, EquiLoop devices, and the TRUFORMA platform in Europe. Financial news, including quarterly results and commentary on diagnostics, therapeutic devices, consumables, and Development Services, provides insight into segment performance and the company’s stated strategy.

Investors and veterinary professionals can also follow Zomedica’s "Fourth Friday at Four" webinar series and related sessions, where the company offers strategic overviews and product-focused presentations. For anyone tracking ZOM news, this page serves as a centralized view of how Zomedica is advancing its veterinary diagnostic, monitoring, and therapeutic platforms, expanding its intellectual property portfolio, and pursuing international growth.